Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...

Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, ...

Christopher Young to Succeed David DeStefano as Vertex’s President and Chief Executive OfficerLeadership Transition to Occur on November 10, ...

Here are the steps to follow and calculate how much you'll pay in taxes Betsy began her career in international finance and it has since grown into a comprehensive approach to journalism as she's been ...

People don't like online forms (gasp!). And it's not hard to see why: Online forms require extra work (and time) and typically stand in the way of a consumer's getting what he or she really wants—such ...

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its third-quarter 2025 results on Nov. 3, after market close. The Zacks Consensus Estimate for the to-be-reported ...

Alphabet-owned Google has agreed to invest a multimillion-pound sum in an instrument which could convert into an equity stake ...

THG Ingenuity, the Altrincham-based e-commerce fulfilment and logistics business, has forged a multimillion-pound deal with ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Amy is an ACA and the CEO and founder of ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Vertex said Tuesday that David DeStefano is retiring as president and chief executive, effective Nov. 10. The company added that its board has named Christopher Young as its new president and CEO, ...

Vertex (VERX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...